Nuclide | Half-life | Radiation energy | Ligand | Chelator | Application | Refs. |
---|---|---|---|---|---|---|
44Sc | 4.04 h | Eβ+ av = 632 keV Eγ = 1157 keV* | PSMA-617 | DOTA | PET (β+-radiation) | Evaluated in this study |
177Lu | 6.65 days | Eβ− av = 134 keV Eγ = 113 keV, 208 keV | PSMA-617 | DOTA | Therapy/SPECT (β−/γ-radiation) | |
68Ga | 68 min | Eβ+ av = 830 keV Eγ = 1077 keV** | PSMA-617 PSMA-11 | DOTA HBED-CC | PET (β+-radiation) | [21] |